Tools

LEADER 02952cam 2200553 i 4500

001 on1062352811;

003 OCoLC;

005 20190419143333.0;

006 m o d f ;

007 cr gn|||||||||;

008 181108s2018 dcu ob f000 0 eng c;

035 a| (Sirsi) o1062352811;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

050 4 a| KF27b| .E553 2018;

074 a| 1019-C-01 (online);

086 0 a| Y 4.C 73/8:115-109;

088 a| Serial no. 115-109 (United States. Congress. House. Committee on Energy and Commerce);

240 10 a| Reauthorization of animal drug user fees (2018)=| ^A490872;

245 10 a| Reauthorization of animal drug user fees :b| ADUFA and AGDUFA : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, March 14, 2018.;

246 30 a| ADUFA and AGDUFA;

264 1 a| Washington :b| U.S. Government Publishing Office,c| 2018.;

300 a| 1 online resource (iii, 132 pages);

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| "Serial no. 115-109.";

500 a| CRDP Program record.;

504 a| Includes bibliographical references.;

588 a| Description based on online resource; title from PDF title page (govinfo, viewed Nov. 8, 2018).;

610 10 a| United States.t| Animal Drug User Fee Act of 2003.=| ^A625601;

610 10 a| United States.t| Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013.=| ^A1166089;

610 20 a| Center for Veterinary Medicine (U.S.)x| Finance.=| ^A429293;

610 20 a| Center for Veterinary Medicine (U.S.)x| Customer services.=| ^A429293;

650 0 a| Drug approvalz| United Statesx| Costs.=| ^A1001108;

650 0 a| Food of animal originx| Government policyz| United States.=| ^A651455;

650 0 a| Fees, Administrativez| United States.=| ^A252852;

655 7 a| Legislative hearings.2| lcgft;

776 08 i| Microfiche version:a| United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.s| Reauthorization of animal drug user fees (2018)w| (OCoLC)1097680969;

856 40 u| https://purl.fdlp.gov/GPO/gpo111405;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 5003078;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5003078-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 12/17/2018x| EDOCUMENTz| JERESOURCE;

Reauthorization of animal drug user fees : ADUFA and AGDUFA : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, March 14, 2018.

Author/creator	United States
Format	Electronic
Publication	Washington : U.S. Government Publishing Office, 2018.
Description	1 online resource (iii, 132 pages)
Supplemental Content	https://purl.fdlp.gov/GPO/gpo111405
Subjects	United States. Animal Drug User Fee Act of 2003. United States. Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013. Center for Veterinary Medicine (U.S.)--Finance. Center for Veterinary Medicine (U.S.)--Customer services. Veterinary drugs--Testing. --Government policy. --United States. Drug approval--United States. --Costs. Food of animal origin--Government policy. --United States. Fees, Administrative--United States.

Uniform title	Reauthorization of animal drug user fees (2018)
Portion of title	ADUFA and AGDUFA
General note	"Serial no. 115-109."
General note	CRDP Program record.
Bibliography note	Includes bibliographical references.
Source of description	Description based on online resource; title from PDF title page (govinfo, viewed Nov. 8, 2018).
Issued in other form	Microfiche version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Reauthorization of animal drug user fees (2018)
Issued in other form	Print version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Reauthorization of animal drug user fees (2018)
Genre/form	Legislative hearings.
Technical rpt number	Serial no. 115-109 (United States. Congress. House. Committee on Energy and Commerce)
GPO item number	1019-C-01 (online)
Govt. docs number	Y 4.C 73/8:115-109

Reauthorization of animal drug user fees : ADUFA and AGDUFA : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, March 14, 2018.

Click here for more information about this title